1. Home
  2. ZVIA vs FHTX Comparison

ZVIA vs FHTX Comparison

Compare ZVIA & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

N/A

Current Price

$0.94

Market Cap

126.3M

ML Signal

N/A

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

N/A

Current Price

$1.79

Market Cap

111.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZVIA
FHTX
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
111.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ZVIA
FHTX
Price
$0.94
$1.79
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$3.67
★ $4.17
AVG Volume (30 Days)
451.5K
★ 685.0K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.88
25.32
EPS
N/A
★ 0.43
Revenue
★ $161,259,000.00
$30,909,000.00
Revenue This Year
$9.55
N/A
Revenue Next Year
$6.45
N/A
P/E Ratio
★ N/A
$4.14
Revenue Growth
4.01
★ 36.75
52 Week Low
$0.96
$1.73
52 Week High
$2.75
$7.61

Technical Indicators

Market Signals
Indicator
ZVIA
FHTX
Relative Strength Index (RSI) 36.32 33.87
Support Level N/A N/A
Resistance Level $1.52 $2.28
Average True Range (ATR) 0.13 0.17
MACD -0.03 0.03
Stochastic Oscillator 0.53 7.27

Price Performance

Historical Comparison
ZVIA
FHTX

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: